Benzinga's Top Initiations

Analysts at SunTrust Robinson Humphrey initiated coverage on Regeneron Pharmaceuticals Inc REGN with a Neutral rating. The target price for Regeneron Pharmaceuticals is set to $450. Regeneron Pharmaceuticals shares closed at $407.81 on Wednesday. KeyBanc initiated coverage on Saia Inc SAIA with a Sector Weight rating. Saia shares closed at $26.66 on Wednesday. Analysts at Numis Securities initiated coverage on GW Pharmaceuticals PLC- ADR GWPH with a Sell rating. GW Pharmaceuticals shares closed at $40.97 on Wednesday. Analysts at B. Riley initiated coverage of Intralinks Holdings Inc IL with a Buy rating. The target price for Intralinks Holdings is set to $14.25. Intralinks Holdings shares closed at $7.79 on Wednesday. Analysts at Berenberg initiated coverage on Alcoa Inc AA with a Hold rating. The target price for eBay is set to $9. Alcoa shares closed at $9.63 on Wednesday. Analysts at Citigroup initiated coverage on Ardelyx Inc ARDX with a Buy rating. The target price for Ardelyx is set to $15. Ardelyx shares closed at $10.54 on Wednesday. Analysts at H.C. Wainwright initiated coverage on Ligand Pharmaceuticals Inc. LGND with a Buy rating. The target price for Ligand Pharmaceuticals is set to $146. Ligand Pharmaceuticals shares closed at $97.54 on Wednesday. Raymond James initiated coverage on RPC, Inc. RES with a Strong Buy rating. The target price for RPC is set to $17. RPC shares closed at $14.16 on Wednesday. Guggenheim Securities initiated coverage on Seres Therapeutics Inc MCRB with a Buy rating. The target price for Seres Therapeutics is set to $41. Seres Therapeutics shares closed at $26.73 on Wednesday. SunTrust Robinson Humphrey initiated coverage of Seattle Genetics, Inc. SGEN with a Neutral rating. The target price for Seattle Genetics is set to $34. Seattle Genetics shares closed at $32.46 on Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsBiotechnologyHealth CareTop Initiations
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!